Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any osteogenesis imperfecta in which the cause of the disease is a mutation in the TMEM38B gene.
Features include always present findings: Femoral bowing, Slender long bone, Increased circulating beta-C-terminal telopeptide concentration, and Weak and brittle bones (osteoporosis) and others; and very common findings: Recurrent fractures. 19 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 8 | Sideways curvature of the spine (scoliosis), Femoral bowing, Slender long bone |
TMEM38B function has not been fully characterized.
Osteogenesis imperfecta type 14 is associated with mutations in the TMEM38B gene on chromosome 9.
Genetic testing for TMEM38B is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for osteogenesis imperfecta type 14 has been reported in the published literature.
Phenotype severity distribution: 6 always present features, 1 very common feature, 2 common features.
No clinical trials have been registered for osteogenesis imperfecta type 14.
46 publications have been identified in PubMed for osteogenesis imperfecta type 14. Research spans Basic Science / Preclinical (33%), Epidemiology / Natural History (22%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 15 | 33% |
Data assembled from 5 of 12 sources · Last updated Sep 20, 2026, 11:11 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Ears | 2 | Hearing loss (hearing impairment), Inner ear hearing loss (sensorineural hearing impairment) |
Lab test results | 2 | Elevated circulating alkaline phosphatase concentration, Increased circulating beta-C-terminal telopeptide concentration |
Growth and development | 1 | Short stature |
Brain and nerves | 1 | Global developmental delay |
Disease patterns and progression
10 |
22% |
Patient case studies | 7 | 15% |
Research summaries | 6 | 13% |
Clinical study results | 5 | 11% |
Other research | 1 | 2% |
Testing and diagnosis research | 1 | 2% |
New treatment approaches | 1 | 2% |
Lu VM (2026). [PMID: 41526788](https://pubmed.ncbi.nlm.nih.gov/41526788/). *Spine Deform*. [Review / Meta-Analysis]
Elhady G (2026). [PMID: 41090974](https://pubmed.ncbi.nlm.nih.gov/41090974/). *Clin Genet*. [Epidemiology / Natural History]
Dure A (2026). [PMID: 42022263](https://pubmed.ncbi.nlm.nih.gov/42022263/). *J Pediatr Soc North Am*. [Gene Therapy / Novel Therapeutics]
Manhal A (2026). [PMID: 41530856](https://pubmed.ncbi.nlm.nih.gov/41530856/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Takada S (2026). [PMID: 41954840](https://pubmed.ncbi.nlm.nih.gov/41954840/). *Spine Deform*. [Case Report / Case Series]
Yamada C (2026). [PMID: 42036523](https://pubmed.ncbi.nlm.nih.gov/42036523/). *Calcif Tissue Int*. [Clinical Trial Publication]
Parviz S (2026). [PMID: 42016334](https://pubmed.ncbi.nlm.nih.gov/42016334/). *Clin Case Rep*. [Case Report / Case Series]
Hald JD (2025). [PMID: 41206390](https://pubmed.ncbi.nlm.nih.gov/41206390/). *Calcif Tissue Int*. [Clinical Trial Publication]
Mulcrone JE (2025). [PMID: 41378917](https://pubmed.ncbi.nlm.nih.gov/41378917/). *J Bone Miner Res*. [Basic Science / Preclinical]
Blokland L (2025). [PMID: 40033490](https://pubmed.ncbi.nlm.nih.gov/40033490/). *Oral Dis*. [Epidemiology / Natural History]